News
The Trump administration is lifting federal requirements for environmental impact statements for oil and gas drilling across ...
The Trump Administration has begun a shift in federal policy related to artificial intelligence (AI) that advocates working ...
The development of oil projects on Alaska's North Slope and in the Arctic is significantly boosting job growth in these ...
Opinion
3dOpinion
WyoFile on MSNNo, selling public lands won’t solve America’s affordable housing crisisColumnist Kerry Drake questions why Wyoming’s congressional delegation is so gung-ho for this wrongheaded approach when more effective solutions exist.
a state-owned economic development entity, for developing commercial mining in a mineral-rich but isolated region of the state. The Biden administration rejected it because there were no active ...
R. Brett James out as director of the city of Jacksonville's Planning and Development Department. The head of the city of ...
We also see in the Golden Dome an echo of the Strategic Defense Initiative (SDI) announced by President Reagan on 23 March ...
A nomination hearing for Trump’s OPM and OMB picks spanned probationary firings and collective bargaining cuts, among other ...
1d
AllAfrica on MSNKwabo Leads Push for Compliance, Value in 2025 Public Sector TargetsThe government of Liberia, through the Ministry of State for Presidential Affairs, has commenced a high-level engagement with heads of public institutions to strategically shape the 2025 performance ...
10d
Independent Newspaper Nigeria on MSNPublic Administration: A Blueprint For Sustainable Institutional GrowthA nation’s progress is not solely measured by economic growth but also by the efficiency, adaptability, and resilience of its public institutions. In Nigeria, public institutions are central to ...
Moving forward, Vivani will focus on developing NPM-115 ... subdermal GLP-1 implants under development for chronic weight management in obese or overweight individuals designed for once or ...
The U.S. Food and Drug Administration (FDA) previously granted orphan drug designation to deucrictibant for the treatment of bradykinin-mediated angioedema in March 2022. "Today, we are diligently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results